Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

540.26 -1.57 (-0.29%)
Streaming Delayed Price Updated: 11:55 AM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about United Therapeutics Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
News headline image
Alphabet And These 2 Healthcare Stocks Insiders Are Selling ↗
The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
United Therapeutics Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
Should SMLF Be On Your Investing Radar? ↗
Sitting at a market capitalization below $2 billion, small cap companies tend to be high-potential stocks compared to their large and mid-cap counterparts but come with higher risks. 
Via Talk Markets
News headline image
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 10 ↗
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Dec. 5-9, 2022. 
Via Talk Markets
News headline image
Our 7 Top Biotech Stock Picks for 2023 ↗
Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023. 
Via InvestorPlace
Morgan Stanley Maintains Overweight Rating for United Therapeutics: Here's What You Need To Know ↗
 
Via Benzinga
Expert Ratings for United Therapeutics ↗
 
Via Benzinga
6 Analysts Have This to Say About United Therapeutics ↗
 
Via Benzinga
News headline image
United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease ↗
 
Via Benzinga
News headline image
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
From United Therapeutics Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 5, 2022 ↗
 
Via Benzinga
News headline image
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
News headline image
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. 
Via Benzinga
News headline image
Recap: United Therapeutics Q3 Earnings ↗
United Therapeutics (NASDAQ:UTHR) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
United Therapeutics Corporation Reports Third Quarter 2022 Financial Results
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Corporation to Present at the Credit Suisse 31st Annual Healthcare Conference
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Posts Data From Remodulin Induction Before Orenitram Therapy In High Blood Pressure Patients ↗
 
Via Benzinga
News headline image
United Therapeutics Announces Top Line Data From the EXPEDITE Study of Remodulin Induction Prior to Orenitram Therapy
From United Therapeutics Corporation
Via Business Wire
News headline image
Earnings Scheduled For November 2, 2022 ↗
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter. 
Via Benzinga
News headline image
United Therapeutics Corporation to Report Third Quarter 2022 Financial Results Before the Market Opens on Wednesday, November 2, 2022
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2022 Annual Meeting
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON 2 Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
From United Therapeutics Corporation
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks. 
Via InvestorPlace
News headline image
United Therapeutics Releases Its Annual Corporate Responsibility Report and Inaugural Public Benefit Report
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics Prevails in Dry Powder Inhaler Patent Litigation
From United Therapeutics Corporation
Via Business Wire
News headline image
United Therapeutics to Feature Clinical Data at the European Society of Cardiology Congress 2022 and the European Respiratory Society International Congress 2022
From United Therapeutics Corporation
Via Business Wire
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
Via Investor Brand Network
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.